Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
In Guru Portfolios
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
| Seth Klarman | Baupost Group | 7.3% | -1.37% |
| C.T. Fitzpatrick | Vulcan Value Partners | 1.8% | -0.47% |
| Kenneth Griffin | CITADEL ADVISORS LLC | 0.1% | -0.04% |
About
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITDA, undervalu
Target Price
The average target price of ELV is 437 and suggests 9.78% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation